Skip to main content
. 2020 May 11;10(5):e035938. doi: 10.1136/bmjopen-2019-035938

Table 4.

Characteristics and symptoms associated with benign renal masses

Characteristic All (n=54) Oncocytoma (n=29) AML (n=8) Other* (n=17)
Age (years) 65 (32–86) 66 (42–86) 63 (59–68) 61 (32–78)
Gender
 Female 29 (53.7) 12 (41.4) 5 (62.5) 12 (70.6)
 Male 25 (46.3) 17 (58.6) 3 (37.5) 5 (29.4)
BMI 27.6 (18.7–45.8) 27.8 (19.4–39.6) 28 (22–38.8) 26.4 (18.7–45.8)
CT size (cm)
 ≤4 22 (44.9) 14 (50) 3 (50) 5 (33.3)
 4< to ≤7 18 (36.7) 11 (39.3) 2 (33.3) 5 (33.3)
 7< to ≤10 6 (12.2) 1 (3.6) 1 (16.7) 4 (26.7)
 >10 3 (6.1) 2 (7.1) 0 (0) 1 (6.7)
 NA 5 (-) 1 (-) 2 (-) 2 (-)
RCC-type symptoms
 No 19 (35.2) 10 (34.5) 4 (50) 5 (29.4)
 Yes 35 (64.8) 19 (65.5) 4 (50) 12 (70.6)
Local symptoms
 No 6 (17.1) 3 (15.8) 1 (25) 2 (16.7)
 Yes 29 (82.9) 16 (84.2) 3 (75) 10 (83.3)
Systemic symptoms
 No 20 (57.1) 12 (63.2) 1 (25) 7 (58.3)
 Yes 15 (42.9) 7 (36.8) 3 (75) 5 (41.7)
Incidental diagnosis
 No 23 (42.5) 13 (44.8) 2 (25) 8 (47)
 Yes 29 (54) 15 (51.7) 6 (75) 8 (47)
 Not known 2 (3.5) 1 (3.5) 0 (0) 1 (6)

*Consists of cystic nephroma (4), benign cyst (3), metanephric adenoma (2), mixed epithelial stromal tumour (2), haemangioblastoma (1), leiomyomata (1), multilocular cyst (1), myxoid mesenchymal tumour (1), Rosai Dorfman disease (1), and solitary fibrous tumour (1).

AML, angiomyolipoma; BMI, body mass index; RCC, renal cell carcinoma.